ResMed's first-quarter result broadly met market expectations, though rising margins and potential for further capital ...
Tariffs on medical devices would push up prices and disrupt research and development efforts at the expense of US patients, ...
Resmed is making another strategic investment in U.S.-based manufacturing and distribution, this time in Indianapolis. The move aims to position the company’s inventory of CPAP devices ...
ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...
Another ASX share that could be a top buy with the $10,000 is ResMed. It is a global leader in sleep apnoea treatment, with a strong portfolio of devices and software solutions that help millions of ...
Key opportunities in the UK sleep apnea devices market include leveraging rising demand for efficient healthcare, expanding AI and ML integration for personalized care, and catering to an aging, ...
Pacific Sleep Apnea Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ...
Respondents saw improved sleep patient volume growth in the last 12 months, but they expect slower growth in the next 12 months, according to the 3Q25 HME Sleep and Oxygen Survey from ...
CEOs Karen Borg and Amrita Blickstead took the reins of the dental sleep appliance maker in February last year, they had some ...
Sleepless nights and anxious minds are becoming an invisible epidemic of the modern age. Experts warn that poor sleep and ...
Earlier this year, Resmed (NYSE: RMD) + unveiled a new comprehensive brand evolution in an effort to streamline its various services. The San Diego-based company — a leader in continuous positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback